Lazanda and Death sudden - a phase IV clinical study of FDA data

Summary:

Death sudden is reported as a side effect among people who take Lazanda (fentanyl citrate), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Oxycontin, and have Pain.

The study is created by eHealthMe based on reports of 202 people who have side effects when taking Lazanda from the FDA, and is updated regularly.

What is Lazanda?

Lazanda has active ingredients of fentanyl citrate. eHealthMe is studying from 203 Lazanda users. Check the latest studies of Lazanda.

On Jun, 18, 2026

202 people reported to have side effects when taking Lazanda.
Among them, 73 people (36.14%) died.

Among these 73 people:

How long have people been on Lazanda when they died? *

What is the gender of people who died when taking Lazanda? *

female: 33.33 %
male: 66.67 %

What is the age of people who died when taking Lazanda? *

What are other drugs people take besides Lazanda? *

What are other side effects people have before they died? *

Thrombocytopenia (decrease of platelets in blood): 1 person, 1.37%
Stomatitis (inflammation of mucous membrane of mouth): 1 person, 1.37%
Rashes (redness): 1 person, 1.37%
Mood Swings (an extreme or rapid change in mood): 1 person, 1.37%
Metastases To Central Nervous System (cancer spreads to central nervous system): 1 person, 1.37%
Malignant Neoplasm Progression (cancer tumour came back): 1 person, 1.37%
Insomnia (sleeplessness): 1 person, 1.37%
Haemoglobin Decreased: 1 person, 1.37%
Dyspnea (difficult or laboured breathing): 1 person, 1.37%
Dry Mouth: 1 person, 1.37%

What are the existing conditions these people have? *

Pain: 7 people, 9.59%
Breakthrough Pain: 3 people, 4.11%
Breast Cancer Female: 2 people, 2.74%
Tumor Pain: 1 person, 1.37%
Thermal Burn (burn by heat): 1 person, 1.37%
Spinal Pain (pain in spine): 1 person, 1.37%
Rectal Cancer (cancer of rectum): 1 person, 1.37%
Neoplasm Malignant (cancer tumour): 1 person, 1.37%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 1.37%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 1.37%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lazanda:

Lazanda (203 reports)

Expand to all the drugs that have ingredients of fentanyl citrate:

Death sudden and drugs with ingredients of fentanyl citrate (17,648 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lazanda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death sudden:

Death sudden (3,716 drugs)

Browse all the conditions that are associated with Death sudden:

Death sudden (3,741 conditions)

Related publications that referenced our studies

Dong H, Zhang J, Ren L, Liu Q, Zhu S, "Unexpected death due to cefuroxime-induced disulfiram-like reaction", Indian journal of pharmacology, 2013 Jan .
Dong H, Zhang J, Ren L, Liu Q, Zhu S, "Unexpected death due to cefuroxime-induced disulfiram-like reaction", Indian journal of pharmacology, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on fentanyl citrate (the active ingredients of Lazanda) and Lazanda (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.